Asia’s Only Industry-Dedicated Forum for Degraders & Proximity Drugs
아시아 유일의 디그레이더 및 프로시미티 약물 전문 산업 포럼
With the first anticipated PROTAC approval and multiple candidates advancing through clinical trials, 2026 is going to be a pivotal year for the global targeted-protein degradation (TPD) industry. This global momentum is fueling Korea’s own TPD boom: over $144M raised in the past 12 months, alongside strategic collaborations from leaders like Ubix Therapeutics, Prazer Therapeutics, and Bridge Biotherapeutics.
The inaugural World TPD & Induced Proximity Summit South Korea is the only event dedicated to gathering the Asian biopharma focused on end-to-end TPD drug development. Featuring key international opinion leaders, deep dives into preclinical and clinical strategy, and expanded content on molecular glues and novel E3 ligases, this summit is your chance to de-risk your pipelines, learn from international experts, and build the global collaborations needed to advance best-in-class TPD therapeutics.
Part of the World Targeted Therapeutics Summit in South Korea organized by Hanson Wade, this is your opportunity to converge with peers working on antibody-drug conjugates (ADCs), Bispecifics, and T-cell engagers, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics.
This conference will showcase the amazing advances being made in TPD and induced proximity in Asia and I am excited by the opportunity to learn about recent progress and build connections with key innovators in the Asia region.
David Barrett, Head, Engineered Small Molecules, Oncology Research, Astellas Pharma
Confirmed Speaker
Hanson Wade Summits have been vital in helping me communicate with experts in TPD drug discovery/development, and it has been an absolute pleasure to participate in them.
Changhoon Ji, Executive Director, AUTOTAC Bio
Confirmed Speaker & Previous Attendee of the TPD Summit Series
An excellent opportunity for companies and academia across Asia working on TPD to come together, share insights, and foster collaborations that can lead to meaningful innovation.
Minoru Tanaka, Director, Tanabe Pharma Corporation
Confirmed Speaker
Download the Preliminary Agenda to Explore:
사전 프로그램 다운로드 및 주요 내용 확인
- Your One-Stop Forum to De-Risk & Develop Best-in-Class TPD Therapeutics
- Insights from 20+ Korean-Based and International Speakers
- Unrivalled Networking Opportunities with Professionals Working on TPD & Induced Proximity, ADCs, Bispecifics & T-Cell Engagers
What To Expect
행사 개요
80+
Attendees from Biopharma & Academia
20+
World-Class Speakers
50%
International Leaders Presenting
8
Hours of In-Person Networking
2
Additional Content Areas to Access: ADCs, & Bispecifics & T-Cell Engager
Official Partners
공식 파트너
Exhibition Partners
Attending Companies Include
참석 기업에는 다음이 포함됩니다
Explore Related Events
관련 행사 둘러보기
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.